BioMarin Pharmaceuticals BMRN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $520.42M+61.5% | $657.24M+156% | $523.88M+155% | ||
| $73.9M-18.9% | $79.56M-17.5% | $82.73M-17.0% | $83.25M-21.7% | $91.15M-13.5% | ||
| $187.17M+3.4% | $181.41M-10.0% | $186.42M-8.8% | $180.64M-13.7% | $181.02M-14.5% | ||
| $874.25M+24.8% | $827.99M+44.5% | $913.98M+120% | $766.77M+133% | $700.26M+150% | ||
| $107.19M+40.9% | $103.04M+20.6% | $81.85M-13.7% | $71.86M-26.7% | $76.09M-22.6% | ||
| $339.52M— | -$414.24M— | -$295.39M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $806.4M— | -$45.55M— | —— | —— | —— | ||
| $2.02B+571% | $368.84M+96.5% | $574.66M— | $241.67M— | $301.81M— | ||
| $767.06M+22.9% | $724.96M+48.7% | $832.13M— | $694.91M— | $624.18M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioMarin Pharmaceuticals generate?
- BioMarin Pharmaceuticals (BMRN) generated $874.3M in operating cash flow over the trailing twelve months.
- What is BioMarin Pharmaceuticals's free cash flow?
- After $107.2M of capital expenditures, BioMarin Pharmaceuticals's free cash flow was $767.1M over the trailing twelve months, up 22.9% year over year.
- Where does BioMarin Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
